Manali Kamdar, MD

Articles by Manali Kamdar, MD

Patient Monitoring to Change After FDA CAR T-Cell Label Update Approval

Manali Kamdar, MDTransplantation & Cellular Therapy | July 18, 2025

Manali Kamdar, MD, assesses the effect on clinical practice from these label updates for CD19- and BCMA-targeting therapies.

Dr. Kamdar Shares Liso-Cel Data From TRANSCEND-MCL Study

Melissa BadamoMantle Cell Lymphoma | July 31, 2024

The study compared treatment response based on prior systemic lines of therapy and prior BTK inhibition in patients with MCL.

Liso-Cel in B-Cell Lymphomas in TRANSFORM Study With Dr. Kamdar

Manali Kamdar, MDTransplantation & Cellular Therapy | August 23, 2024

Manali Kamdar, MD, shared results from the pivotal phase III TRANSFORM study on lisocabtagene maraleucel in LBCL.